Brief: Somnomed Posts Q2 Fy23 Revenue Of A$21.4 Million
30/01/2023 01:32
Jan 30 (Reuters) - Somnomed Ltd SOM.AX :
* Q2 FY23 REVENUE OF A$21.4 MILLION, UP 16.6% VERSUS
PREVIOUS
CORRESPONDING PERIOD
* SEES FY23 REVENUE GROWTH GUIDANCE HAS BEEN REVISED TO
BETWEEN
15-20%
* SEES FY23 EBITDA GUIDANCE OF A$2M+, REMAINS UNCHANGED
Source text for Eikon: ID:nASX64BZgB
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million